Lithium induced alterations in rat ganglionic lipids.
Superior cervical ganglia from normal or lithium fed rats were incubated in vitro with [U-14C]pyruvic acid, in Krebs-Ringer solution with or without lithium ion. Acute lithium incubations were performed on ganglia from normal rats with 25 mEquiv./l of lithium ion, while chronic incubations were performed on ganglia from lithium fed rats with 0.5 mEquiv./l lithium in the bathing solution. Lipids were extracted, separated by thin layer chromatography and specific activities of individual lipids and their fatty acids determined. In control ganglia shinogolipids contained 60-70% of the lipid radioactivity, glycerophospholipids 20-30% and neutral lipids 10-25%. Phosphatidylcholine contained 65% of the glycerophospholipid label and 40% of the lipid phosphorus, while sphingomyelin contained 90% of the sphingolipid label and exhibited the highest specific activity over all. Cholesterol was the major neutral lipid. Niety-five per cent of the glycerophospholipid label and 4% of the sphingomyelin label was localized in the fatty acids. The lipid and fatty acid compositions of all ganglia were similar. However the lipid radioactivity in chronic ganglia was lower than in control, with the sphingolipids most affected. In 80 min stimulated chronic ganglia stearic and oleic acid, radioactivity was depressed with respect to both control fatty acids and to the [14C]palmitate of chronic tissues. In both chronic and acute lithium ganglia stimulated for 80 min, the specific activities of phosphatidylinositol were significantly lower than in control. In contrast to control, the labeling of sphingolipids in resting acute ganglia was higher than in stimulated tissues.
D000818:Animals; D002784:Cholesterol / Q000096:biosynthesis; D004558:Electric Stimulation; D005227:Fatty Acids / Q000096:biosynthesis; D005725:Ganglia, Autonomic / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D005994:Glycerophosphates / Q000096:biosynthesis; D008055:Lipids / Q000096:biosynthesis*; D008094:Lithium / Q000494:pharmacology*; D010713:Phosphatidylcholines / Q000096:biosynthesis; D010743:Phospholipids / Q000096:biosynthesis; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D013107:Sphingolipids / Q000096:biosynthesis; D013109:Sphingomyelins / Q000096:biosynthesis
D005227:Fatty Acids; D005994:Glycerophosphates; D008055:Lipids; D010713:Phosphatidylcholines; D010743:Phospholipids; D011773:Pyruvates; D013107:Sphingolipids; D013109:Sphingomyelins; D002784:Cholesterol; D008094:Lithium